Last 6 graded trials from the audit log.
| Timestamp | Trial | Model | Grade | Form | Status |
|---|---|---|---|---|---|
| 2026-06-29T10:28:05 | Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer | deepseek-reasoner | 4 | 2A | Success |
| 2026-06-29T10:23:12 | Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer | deepseek-reasoner | 4 | 2A | Success |
| 2026-06-29T10:16:22 | Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer | deepseek-reasoner | 4 | Form 2A (via override from Form 2C) | Success |
| 2026-06-29T10:08:44 | Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer | deepseek-reasoner | - | - | Success |
| 2026-06-29T09:15:08 | KRASG12C Inhibition with Sotorasib in Advanced Solid Tumor | deepseek-reasoner | - | - | Success |
| 2026-06-29T09:13:42 | KRASG12C Inhibition with Sotorasib in Advanced Solid Tumor | deepseek-reasoner | - | - | Success |